Literature DB >> 7804740

Thrombin-induced endothelial cell dysfunction.

M J Rabiet1, J L Plantier, E Dejana.   

Abstract

Endothelium is a multifunctional organ which can directly influence circulating blood components as well as other cells within the vessel wall. The clotting enzyme thrombin, generated at the surface of damaged endothelium, induces blood coagulation but also exerts a variety of functional effects on the endothelium itself. Thrombin acts on endothelial cells to stimulate synthesis and release of various agents, such as inflammatory mediators, vasoactive substances and growth factors. It causes leukocyte adhesion to the endothelium by triggering expression of adhesion molecules on the cell surface and causes disruption of endothelial permeability properties. The majority of thrombin effects on endothelial cells are mediated by its receptor and require its lytic activity. Differences have been observed among the response to thrombin of endothelial cells of different origin. In general microvascular endothelial cells appear to be particularly sensitive to this enzyme. Thrombin induced microvascular dysfunction can have pathological consequences and contribute to organ reactions to inflammation and ischaemia.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7804740     DOI: 10.1093/oxfordjournals.bmb.a072935

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  8 in total

Review 1.  Challenges and emerging technologies in the immunoisolation of cells and tissues.

Authors:  John T Wilson; Elliot L Chaikof
Journal:  Adv Drug Deliv Rev       Date:  2007-10-11       Impact factor: 15.470

2.  Protease-activated receptor-3 (PAR3) regulates PAR1 signaling by receptor dimerization.

Authors:  Joseph N McLaughlin; Myla M Patterson; Asrar B Malik
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-21       Impact factor: 11.205

3.  Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo.

Authors:  M Corada; M Mariotti; G Thurston; K Smith; R Kunkel; M Brockhaus; M G Lampugnani; I Martin-Padura; A Stoppacciaro; L Ruco; D M McDonald; P A Ward; E Dejana
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

4.  Thrombin activates a Y box-binding protein (DNA-binding protein B) in endothelial cells.

Authors:  O I Stenina; E J Poptic; P E DiCorleto
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

5.  Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation.

Authors:  P Gresele; S Momi; M Berrettini; G G Nenci; H P Schwarz; N Semeraro; M Colucci
Journal:  J Clin Invest       Date:  1998-02-01       Impact factor: 14.808

6.  Thrombosis and inflammation in intraportal islet transplantation: a review of pathophysiology and emerging therapeutics.

Authors:  John T Wilson; Elliot L Chaikof
Journal:  J Diabetes Sci Technol       Date:  2008-09

7.  Biomolecular surface engineering of pancreatic islets with thrombomodulin.

Authors:  John T Wilson; Carolyn A Haller; Zheng Qu; Wanxing Cui; Murali K Urlam; Elliot L Chaikof
Journal:  Acta Biomater       Date:  2010-01-25       Impact factor: 8.947

8.  Pharmacological inhibition of PAI-1 alleviates cardiopulmonary pathologies induced by exposure to air pollutants PM2.5.

Authors:  Asish K Ghosh; Saul Soberanes; Elizabeth Lux; Meng Shang; Raul Piseaux Aillon; Mesut Eren; G R Scott Budinger; Toshio Miyata; Douglas E Vaughan
Journal:  Environ Pollut       Date:  2021-05-07       Impact factor: 8.071

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.